For the Inventor, By the Inventor

Enter assignee name

Montpellier, France

Centre Hospitalier Universitaire De Montpellier

USPTO Granted Patents = 25

CIPO Patents = 11

EPO Patents = 28

Forward Citations = 19

Loading Chart...

Loading Chart...

96 inventors (with patents filed for the assignee):

Samir Hamamah (11 out of 15 patents)

Said Assou (5 out of 7 patents)

Jérôme Moreaux (5 out of 6 patents)

4. Christian Hamel (3 out of 3 patents)

5. Sabine Traver (3 out of 4 patents)

6. Elodie Scalici (3 out of 4 patents)

7. Delphine Haouzi (2 out of 3 patents)

8. Philippe Brabet (2 out of 3 patents)

9. David Cia (2 out of 2 patents)

10. Laurent Guillou (2 out of 2 patents)

11. Claire Vigor (2 out of 2 patents)

12. Thierry Durand (2 out of 5 patents)

13. Céline Crauste (2 out of 5 patents)

14. Joseph Vercauteren (2 out of 4 patents)

15. Bernard Klein (2 out of 2 patents)

25 patents: Sort by Forward Citations

1. 12071671 - Methods for the in vitro determination of the outcome and for the treatment of individuals having multiple myeloma (2024-08-27),

2. 11499197 - Prognosis method of multiple myeloma (2022-11-15),

3. 11230736 - Methods for assessing pregnancy outcome (2022-01-25),

4. 11149314 - Methods for determining the quality of an embryo (2021-10-19),

5. 11014947 - Lipophenol compounds and uses thereof (2021-05-25),

6. 10969391 - Methods for diagnosing hematological cancers (2021-04-06),

7. 10925951 - Vaccination against diabetes, obesity and complications thereof (2021-02-23),

8. 10731218 - Methods employing circulating DNA and miRNA as biomarkers for female infertility (2020-08-04),

9. 10676791 - Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma (2020-06-09),

10. 10662481 - Methods for predicting response to HDACi/DNMTi combination in multiple myeloma (2020-05-26),

11. 10400282 - Methods employing circulating DNA and miRNA as biomarkers for female infertility (2019-09-03),

12. 10184150 - Free nucleic acids and miRNA as non-invasive method for determining embryo quality (2019-01-22),

13. 10174380 - Methods for predicting multiple myeloma treatment response (2019-01-08),

14. 10105452 - Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject (2018-10-23),

15. 10059994 - Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome (2018-08-28),

The Centre Hospitalier Universitaire de Montpellier (CHU Montpellier) is a leading university hospital in France. It is affiliated with the University of Montpellier and serves as a major medical and research institution. With a strong focus on patient care, the hospital offers a wide range of medical services and specialties. CHU Montpellier is renowned for its innovative research programs and collaborations with national and international partners. Its website provides comprehensive information about the hospital's services, departments, medical staff, research activities, and educational programs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

25 Patents

#6 in Montpellier

#812 in France

#24,897 in the World

Montpellier, France

Centre Hospitalier Universitaire De Montpellier

Forward Citations = 19

96 inventors:

Samir Hamamah (11 out of 15 patents)

Said Assou (5 out of 7 patents)

Jérôme Moreaux (5 out of 6 patents)

4. Christian Hamel (3 out of 3 patents)

5. Sabine Traver (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…